Yield10 Bioscience Inc
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, … Read more
Yield10 Bioscience Inc (YTEN) - Net Assets
Latest net assets as of June 2024: $-6.24 Million USD
Based on the latest financial reports, Yield10 Bioscience Inc (YTEN) has net assets worth $-6.24 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.97 Million) and total liabilities ($9.21 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-6.24 Million |
| % of Total Assets | -210.18% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -113.21% |
| Growth Volatility | 72.16 |
Yield10 Bioscience Inc - Net Assets Trend (2002–2023)
This chart illustrates how Yield10 Bioscience Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Yield10 Bioscience Inc (2002–2023)
The table below shows the annual net assets of Yield10 Bioscience Inc from 2002 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-2.48 Million | -156.43% |
| 2022-12-31 | $4.40 Million | -72.54% |
| 2021-12-31 | $16.03 Million | +68.13% |
| 2020-12-31 | $9.53 Million | +333.34% |
| 2019-12-31 | $-4.08 Million | -171.69% |
| 2018-12-31 | $5.70 Million | -57.80% |
| 2017-12-31 | $13.50 Million | +112.00% |
| 2016-12-31 | $6.37 Million | -51.11% |
| 2015-12-31 | $13.03 Million | -30.69% |
| 2014-12-31 | $18.80 Million | -7.85% |
| 2013-12-31 | $20.40 Million | -56.91% |
| 2012-12-31 | $47.34 Million | +19.96% |
| 2011-12-31 | $39.46 Million | +66.68% |
| 2010-12-31 | $23.68 Million | -56.99% |
| 2009-12-31 | $55.04 Million | -6.85% |
| 2008-12-31 | $59.09 Million | -33.76% |
| 2007-12-31 | $89.20 Million | -18.60% |
| 2006-12-31 | $109.59 Million | +335.38% |
| 2005-12-31 | $-46.56 Million | -19.47% |
| 2004-12-31 | $-38.97 Million | -35.36% |
| 2002-12-31 | $-28.79 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Yield10 Bioscience Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 38329700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $120.00K | % |
| Other Comprehensive Income | $-265.00K | % |
| Other Components | $411.81 Million | % |
| Total Equity | $-2.48 Million | 100.00% |
Yield10 Bioscience Inc Competitors by Market Cap
The table below lists competitors of Yield10 Bioscience Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Skillcast Group PLC
LSE:SKL
|
$8.07K |
|
Golden Textiles & Clothes Wool
EGX:GTWL
|
$8.07K |
|
TF703
SA:TF703
|
$8.08K |
|
EAPBF
OTCGREY:EAPBF
|
$8.08K |
|
Fingerprint Cards AB (publ)
OTCGREY:FGRRF
|
$8.06K |
|
United Royale Holdings Corp
OTCQB:URYL
|
$8.06K |
|
Alternative Investment Trust
AU:AIQ
|
$8.06K |
|
Taiwan Bio Therapeutics Co., Ltd
TWO:6892
|
$8.06K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Yield10 Bioscience Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 4,400,000 to -2,483,000, a change of -6,883,000 (-156.4%).
- Net loss of 14,455,000 reduced equity.
- Share repurchases of 41,000 reduced equity.
- New share issuances of 5,945,000 increased equity.
- Other comprehensive income decreased equity by 36,000.
- Other factors increased equity by 1,704,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-14.46 Million | -582.16% |
| Share Repurchases | $41.00K | -1.65% |
| Share Issuances | $5.95 Million | +239.43% |
| Other Comprehensive Income | $-36.00K | -1.45% |
| Other Changes | $1.70 Million | +68.63% |
| Total Change | $- | -156.43% |
Book Value vs Market Value Analysis
This analysis compares Yield10 Bioscience Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $-564529.41 | $0.02 | x |
| 2004-12-31 | $-618589.13 | $0.02 | x |
| 2005-12-31 | $-739013.90 | $0.02 | x |
| 2006-12-31 | $1178365.59 | $0.02 | x |
| 2007-12-31 | $9732.90 | $0.02 | x |
| 2008-12-31 | $6209.65 | $0.02 | x |
| 2009-12-31 | $136585.61 | $0.02 | x |
| 2010-12-31 | $51469.57 | $0.02 | x |
| 2011-12-31 | $73487.90 | $0.02 | x |
| 2012-12-31 | $80373.51 | $0.02 | x |
| 2013-12-31 | $34456.08 | $0.02 | x |
| 2014-12-31 | $17799.24 | $0.02 | x |
| 2015-12-31 | $5053.53 | $0.02 | x |
| 2016-12-31 | $2220.71 | $0.02 | x |
| 2017-12-31 | $3981.72 | $0.02 | x |
| 2018-12-31 | $550.74 | $0.02 | x |
| 2019-12-31 | $-268.63 | $0.02 | x |
| 2020-12-31 | $96.39 | $0.02 | x |
| 2021-12-31 | $81.28 | $0.02 | x |
| 2022-12-31 | $21.49 | $0.02 | x |
| 2023-12-31 | $-7.50 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Yield10 Bioscience Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24091.67%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-83.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | -260.83% | 0.00x | 0.00x | $-2.31 Million |
| 2004 | 0.00% | -137.42% | 0.49x | 0.00x | $-1.16 Million |
| 2005 | 0.00% | -274.20% | 0.38x | 0.00x | $-2.97 Million |
| 2006 | -14.66% | -349.93% | 0.04x | 1.16x | $-27.02 Million |
| 2007 | -31.25% | -1656.27% | 0.01x | 1.33x | $-36.80 Million |
| 2008 | -60.93% | -2315.43% | 0.02x | 1.64x | $-41.91 Million |
| 2009 | -68.96% | -2663.65% | 0.01x | 1.77x | $-43.46 Million |
| 2010 | -163.89% | -8661.38% | 0.01x | 2.82x | $-41.17 Million |
| 2011 | -98.28% | -2721.75% | 0.02x | 2.10x | $-42.73 Million |
| 2012 | 7.67% | 8.58% | 0.79x | 1.13x | $-1.10 Million |
| 2013 | -149.55% | -565.55% | 0.20x | 1.31x | $-32.55 Million |
| 2014 | -157.13% | -1054.79% | 0.12x | 1.23x | $-31.41 Million |
| 2015 | -181.77% | -912.91% | 0.15x | 1.31x | $-24.98 Million |
| 2016 | -119.39% | -656.08% | 0.11x | 1.69x | $-8.24 Million |
| 2017 | -69.59% | -995.34% | 0.06x | 1.25x | $-10.75 Million |
| 2018 | -161.20% | -1651.98% | 0.04x | 2.27x | $-9.75 Million |
| 2019 | 0.00% | -1607.44% | 0.05x | 0.00x | $-12.55 Million |
| 2020 | -107.07% | -1277.35% | 0.06x | 1.52x | $-11.16 Million |
| 2021 | -68.83% | -1796.58% | 0.03x | 1.27x | $-12.63 Million |
| 2022 | -308.32% | -3014.67% | 0.06x | 1.84x | $-14.01 Million |
| 2023 | 0.00% | -24091.67% | 0.02x | 0.00x | $-14.21 Million |
Industry Comparison
This section compares Yield10 Bioscience Inc's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $1,234,454,915
- Average return on equity (ROE) among peers: -88.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Yield10 Bioscience Inc (YTEN) | $-6.24 Million | 0.00% | N/A | $8.06K |
| Argo Living Soils Corp (ARLSF) | $117.11K | -241.15% | 0.57x | $4.77 Million |
| American Vanguard Corporation (AVD) | $282.36 Million | 4.53% | 0.52x | $93.02 Million |
| Bee Vectoring Technologies International Inc (BEVVF) | $1.82 Million | -170.52% | 0.16x | $47.51K |
| Benson Hill, Inc. Common Stock (BHIL) | $86.04 Million | -134.02% | 2.19x | $178.85K |
| BHILW (BHILW) | $86.04 Million | -134.02% | 2.19x | $286.16K |
| Bioceres Crop Solutions Corp (BIOX) | $351.38 Million | 0.92% | 1.43x | $16.37 Million |
| CO2 Gro Inc (BLONF) | $577.93K | -224.34% | 1.65x | $154.65K |
| China BlueChemical Ltd (CBLUF) | $7.05 Billion | 23.77% | 0.29x | $484.41 Million |
| CF Industries Holdings Inc (CF) | $4.39 Billion | 15.96% | 1.90x | $15.33 Billion |
| China Green Agriculture Inc (CGA) | $100.10 Million | -28.38% | 0.63x | $14.93 Million |